Cohen Joshua B
SEC CIK 1898644 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | Co-CEO, Dir | 3.61M | — | $7.39M | 28 | 2022-01-06 | 2026-09-10 |
Most active insiders at AMLX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Klee Justin B. | Co-CEO, Dir | — | $4.03M |
| 2 | Cohen Joshua B | Co-CEO, Dir | — | $4.03M |
| 3 | Mazzariello Gina | CLO | — | $1.18M |
| 4 | FRATES JAMES M | CFO | — | $708.4K |
| 5 | Bedrosian Camille L | Chief Medical Off | — | $689.0K |
| 6 | Firestone Karen | Dir | $152.2K | — |
| 7 | MILNE GEORGE M JR | Dir | — | — |
Transactions 28
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-09-14 16:00 | 2026-09-10 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | S - Sale | $32.19 | -30.5K | 3.61M | -0.8% | -$980.5K |
| 2026-08-20 21:00 | 2026-08-18 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | A - Grant | $0.00 | +60.0K | 3.64M | +2% | $0 | |
| D | 2026-03-09 | 2026-03-05 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | A - Grant | $0.00 | +248.9K | 3.58M | +7% | $0 |
| 2026-03-04 | 2026-03-02 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | S - Sale | $14.48 | -29.3K | 3.33M | -0.9% | -$424.0K | |
| 2026-02-04 | 2026-02-02 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | S - Sale | $14.68 | -15.5K | 3.36M | -0.5% | -$227.5K | |
| DM | 2026-01-20 | 2026-01-15+ | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | M - OptEx | $7.57 | +200.0K | 3.51M | +6% | +$1.51M |
| DM | 2026-01-20 | 2026-01-15+ | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | S - Sale+OE | $13.59 | -138.2K | 3.38M | -4% | -$1.88M |
| 2026-01-08 | 2026-01-06 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | S - Sale | $11.09 | -7,715 | 3.32M | -0.2% | -$85.6K | |
| M | 2025-10-02 | 2025-09-30 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | S - Sale | $14.34 | -29.9K | 3.33M | -0.9% | -$429.4K |
| 2025-04-02 | 2025-03-31 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | S - Sale | $3.47 | -21.5K | 3.36M | -0.6% | -$74.6K | |
| D | 2025-03-10 | 2025-03-06 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | A - Grant | $0.00 | +180.1K | 3.38M | +6% | $0 |
| 2025-03-05 | 2025-03-03 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | S - Sale | $3.17 | -4,595 | 3.20M | -0.1% | -$14.6K | |
| 2025-02-05 | 2025-02-03 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | S - Sale | $3.47 | -11.9K | 3.20M | -0.4% | -$41.1K | |
| 2025-01-08 | 2025-01-06 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | S - Sale | $4.05 | -7,471 | 3.21M | -0.2% | -$30.3K | |
| 2024-10-02 | 2024-09-30 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | S - Sale | $3.20 | -18.6K | 3.22M | -0.6% | -$59.5K | |
| D | 2024-09-25 | 2024-09-23 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | M - OptEx | $1.57 | +1,857 | 3.24M | +0.1% | +$2,915 |
| D | 2024-09-16 | 2024-09-12 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | M - OptEx | $1.57 | +34.4K | 3.24M | +1% | +$54.1K |
| D | 2024-04-18 | 2024-04-16 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | A - Grant | $0.00 | +179.8K | 3.20M | +6% | $0 |
| 2024-03-07 | 2024-03-05 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | S - Sale | $18.73 | -4,135 | 3.02M | -0.1% | -$77.4K | |
| D | 2024-02-28 | 2024-02-26 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | A - Grant | $0.00 | +126.7K | 3.03M | +4% | $0 |
| 2024-01-11 | 2024-01-09 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | S - Sale | $16.33 | -5,841 | 2.90M | -0.2% | -$95.4K | |
| D | 2023-11-20 | 2023-11-16 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | M - OptEx | $1.57 | +63.7K | 2.91M | +2% | +$100.0K |
| D | 2023-03-20 | 2023-03-16 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | A - Grant | $0.00 | +50.0K | 2.84M | +2% | $0 |
| DM | 2023-03-20 | 2023-03-16 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | S - Sale | $31.86 | -100.0K | 2.79M | -3% | -$3.19M |
| M | 2023-01-10 | 2023-01-06 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | S - Sale | $36.30 | +5,968 | 2.89M | +0.2% | +$216.6K |
| D | 2022-05-06 | 2022-05-05 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | M - OptEx | $0.37 | +334.5K | 2.90M | +13% | +$123.8K |
| D | 2022-01-10 | 2022-01-06 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | A - Grant | $0.00 | +75.0K | 2.56M | +3% | $0 |
| D | 2022-01-10 | 2022-01-06 | AMLX | Amylyx Pharmaceuticals, Inc. | Cohen Joshua B | Co-CEO, Dir | C - Cnv Deriv | $0.00 | +4,870 | 2.49M | +0.2% | $0 |
Purchase Sale Sale after option exercise All abbreviations